Arthralgia (joint pain) is listed as an adverse reaction in the UK Summaries of Product Characteristics (SmPCs) for approved incretin-based therapies
Jensen L, Helleberg H, Roffel A, van Lier JJ, Bjrnsdottir I, Pedersen PJ, et al
You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider
That the safety profile looked very strong and we could offer a GLP-1 off our platform and do it in a safe, high-quality way is why we decided to move forward with it." Once consistent supply is available through the pharmacies' wholesaler, Hims & Hers plans to make branded options available to customers, expanding the offering beyond the current oral medication kits and compounded GLP-1 injectable medications
This article seeks to consider the nutritional implications of GLP-1 drugs as we await more specific, science-backed dietary guidelines
NAION is thought to be caused by reduced blood flow to the optic nerve head, with the consequence of permanent visual loss in one eye